The Latest Breaking News from Lupus

Pauline Follett, who lives with cerebral lupus, has had two National Disability Insurance Scheme applications rejected within three years. According to a Disability Advocacy NSW report, people in remote areas of NSW face challenges in providing the evidence required.

Here's a roundup of top developments in the biotech space over the last 24 hours:

Gainers Kezar Life Sciences, Inc. (NASDAQ: KZR) rose 78% to $10.29 in pre-market trading after the company reported positive topline results from the MISSION Phase 2 clinical trial evaluating zetomipzomib in patients with active lupus nephritis (LN).

Kezar Life Sciences, Inc. (NASDAQ: KZR) reported positive topline results from the MISSION Phase 2 clinical trial evaluating zetomipzomib in patients with active lupus nephritis (LN).

MYSURU

From stress to sunlight to hormones, here are five common factors that can contribute to a flare-up of Lupus symptoms.

A UK CHAIRTY is urging the public to join efforts to raise awareness of an incurable autoimmune disease as World Lupus Day is marked.

Wells Fargo is reiterating its Overweight rating after Kezar Life Sciences Inc's (NASDAQ:KZR) zeto (KZR-616) Phase 2 trial in dermatomyositis/polymyositis failed to top placebo on the trial's primary endpoint of mean total improvement score (TIS). The analysts had viewed the program as a free call option for shares at these levels and argued that there…

Lupus is a long-term condition that causes joint pain and skin rashes and has no cure.